The effect of Methylphenidate on sleep and circadian rhythm in adult ADHD measured with actigraphy and the dim light melatonin onset (DLMO)

The effect of Methylphenidate on sleep and circadian rhythm in adult ADHD measured with actigraphy and the dim light melatonin onset (DLMO) - The effect of methylphenidate on circadian rhythm in Adult ADHD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35707

Enrollment

Registered

2012-03-02

Start date

2012-04-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention deficit/hyperactivity

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult ADHD patients between 21-60 years old

Exclusion criteria

Exclusion criteria: Use of medication which influences sleep and/or the endogenous melatonin production recent traveling within more than one time zone or participation in shift work Substance abuse Contraindications for the use of methylphenidate

Design outcomes

Primary

Measure	Time frame
DLMO (Dim light melatonin onset) Circadian actografic parameters PAD (phase angle difference)	—

Secondary

Measure	Time frame
subjective sleepparameters measured with self reporting lists	—

Countries

Netherlands

Outcome results